Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Mona Thapa, Ismene Petrakis & Elizabeth Ralevski. (2017) A Comparison of Sexual Side Effects of Antidepressants With and Without Naltrexone. Journal of Dual Diagnosis 13:3, pages 230-235.
Read now
Read now
NormaL. McCoy. (2002) Longitudinal study of menopause and sexuality. Acta Obstetricia et Gynecologica Scandinavica 81:7, pages 617-622.
Read now
Read now
Jerome Goldstein. (2001) Sexual aspects of headache. Postgraduate Medicine 109:1, pages 81-92.
Read now
Read now
Mark Alan Winton. (2000) The Medicalization of Male Sexual Dysfunctions: An Analysis of Sex Therapy Journals. Journal of Sex Education and Therapy 25:4, pages 231-239.
Read now
Read now
AlanJ. Cohen & Barbara Bartlik. (1998) Ginkgo biloba for antidepressant-induced sexual dysfunction. Journal of Sex & Marital Therapy 24:2, pages 139-143.
Read now
Read now
David S Baldwin, Sally C Thomas & Jon Birtwistle. (1997) Effects of antidepressant drugs on sexual function. International Journal of Psychiatry in Clinical Practice 1:1, pages 47-58.
Read now
Read now
Articles from other publishers (27)
Jungao Huang, Xuan Xiao, Linyu Zhang, Shanfeng Gao, Xia Wang & Juan Yang. (2023) The effect of serum calcium on the association of depression with infertility among U.S. women. Heliyon 9:11, pages e22220.
Crossref
Crossref
Eve Overton, Erin Hofstatter, Devin Miller & Elena Ratner. 2017. Essentials of Menopause Management. Essentials of Menopause Management
303
322
.
Yael I. Nillni, Amelia K. Wesselink, Jaimie L. Gradus, Elizabeth E. Hatch, Kenneth J. Rothman, Ellen M. Mikkelsen & Lauren A. Wise. (2016) Depression, anxiety, and psychotropic medication use and fecundability. American Journal of Obstetrics and Gynecology 215:4, pages 453.e1-453.e8.
Crossref
Crossref
Luigi Lombardo & Roberta Rossi. (2014) Disfunzioni sessuali correlate al trattamento del disturbo depressivo maggiore con farmaci antidepressivi. RIVISTA DI SESSUOLOGIA CLINICA:2, pages 57-80.
Crossref
Crossref
Jin Ho Park. 2011. Mood and Anxiety Related Phenotypes in Mice. Mood and Anxiety Related Phenotypes in Mice
357
373
.
Domenic A. Ciraulo, Richard I. Shader & David J. Greenblatt. 2011. Pharmacotherapy of Depression. Pharmacotherapy of Depression
33
124
.
Kyoung-Uk LeeYoung Min LeeJi-Min NamHae-Kook LeeYong-Sil KweonChung Tai LeeTae-Youn Jun. (2010) Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting. Psychiatry Investigation 7:1, pages 55.
Crossref
Crossref
Sean M. Laurent & Anne D. Simons. (2009) Sexual dysfunction in depression and anxiety: Conceptualizing sexual dysfunction as part of an internalizing dimension. Clinical Psychology Review 29:7, pages 573-585.
Crossref
Crossref
. 2007. Male Sexual Dysfunction. Male Sexual Dysfunction
373
376
.
. 2007. Male Sexual Dysfunction. Male Sexual Dysfunction
103
112
.
Joseph J. Lévy & Catherine Garnier. (2007) Drogues, médicaments et sexualité. Drogues, santé et société 5:2, pages 11-48.
Crossref
Crossref
Glen L. Stimmel & Mary A. Gutierrez. (2014) Sexual Dysfunction and Psychotropic Medications. CNS Spectrums 11:S9, pages 24-30.
Crossref
Crossref
Gook Jun Ahn, Kyung Koo Kang, Dong Sung Kim, Byoung Ok Ahn, Won Bae Kim, Sung Keun Kang, Byeong Chun Lee & Woo Suk Hwang. (2005) DA-8159 reverses selective serotonin reuptake inhibitor-induced erectile dysfunction in rats. Urology 65:1, pages 202-207.
Crossref
Crossref
Adrienne J. Lindblad, Lisa R. Grandy Allen & Theresa A. Hurley. (2004) Antidepressant-Induced Sexual Dysfunction. Child and Adolescent Psychopharmacology News 9:3, pages 1-8.
Crossref
Crossref
Domenic A. Ciraulo, Lucy Tsirulnik-Barts, Richard I. Shader & David J. Greenblatt. 2004. Pharmacotherapy of Depression. Pharmacotherapy of Depression
33
117
.
Alvaro Morales. (2003) Erectile dysfunction:. Clinics in Geriatric Medicine 19:3, pages 529-538.
Crossref
Crossref
Stefan Ückert, Mark H. Fuhlenriede, Armin J. Becker, Christian G. Stief, Friedemann Scheller, Wolfram H. Knapp, Wolf G. Forssmann & Udo Jonas. (2003) Is serotonin significant for the control of penile flaccidity and detumescence in the human male?. Urological Research 31:2, pages 55-60.
Crossref
Crossref
Murad Atmaca, Murat Kuloglu, Ertan Tezcan & Ayten Buyukbayram. (2003) Switching to tianeptine in patients with antidepressant‐induced sexual dysfunction. Human Psychopharmacology: Clinical and Experimental 18:4, pages 277-280.
Crossref
Crossref
JM Flack. (2002) THE EFFECT OF DOXAZOSIN ON SEXUAL FUNCTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA, HYPERTENSION, OR BOTH. International Journal of Clinical Practice 56:7, pages 527-530.
Crossref
Crossref
Norma L. McCoy. (2002) Longitudinal study of menopause and sexuality. Acta Obstetricia et Gynecologica Scandinavica 81:7, pages 617-622.
Crossref
Crossref
Fouad R. Kandeel, Vivien K. T. Koussa & Ronald S. Swerdloff. (2001) Male Sexual Function and Its Disorders: Physiology, Pathophysiology, Clinical Investigation, and Treatment. Endocrine Reviews 22:3, pages 342-388.
Crossref
Crossref
Ian Eardley, Robert Morgan, Wallace Dinsmore, Paula Yates & Mitradev Boolell. (2018) Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction. British Journal of Psychiatry 178:4, pages 325-330.
Crossref
Crossref
M. Philipp, J.W.G. Tiller, D. Baier & R. Kohnen. (2000) Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. European Neuropsychopharmacology 10:5, pages 305-314.
Crossref
Crossref
. (2000) Letters to the Editor. The Canadian Journal of Psychiatry 45:2, pages 196-202.
Crossref
Crossref
Andy Levy, Tessa Crowley & Clive Gingell. (2000) Non-surgical management of erectile dysfunction. Clinical Endocrinology 52:3, pages 253-260.
Crossref
Crossref
Mark J. Millan, Adrian Newman-Tancredi, Val�rie Audinot, Didier Cussac, Fran�oise Lejeune, Jean-Paul Nicolas, Francis Cog�, Jean-Pierre Galizzi, Jean A. Boutin, Jean-Michel Rivet, Anne Dekeyne & Alain Gobert. (2000) Agonist and antagonist actions of yohimbine as compared to fluparoxan at ?2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse 35:2, pages 79-95.
Crossref
Crossref
Michelle V. Lambert & Mary M. Robertson. (1999) Depression in Epilepsy: Etiology, Phenomenology, and Treatment. Epilepsia 40:s10, pages s21-s47.
Crossref
Crossref